• Home
  • Why Is Clover Health And Wellness (CLOV) Stock Up Today? Director Chelsea Clinton bought 100,000 shares of CLOV stock 

Why Is Clover Health And Wellness (CLOV) Stock Up Today? Director Chelsea Clinton bought 100,000 shares of CLOV stock 

Right now, shareholders of Clover Wellness (NASDAQ: CLOV) are grinning ear to ear. Although clov stock chart stays down greater than 25% year-to-date (YTD), shares of the firm are up over 20% today.

Why exactly is Clover Health and wellness trading higher today?

Over the weekend break, it was reported that Clover director Chelsea Clinton had recently bought shares of CLOV stock. The deal, which took place on March 3, saw Clinton buy 100,000 shares for an average rate of $2.52 per share. In total, Clinton’s current transaction amounted to $252,530, according to a Kind 4 submitted to the united state Securities and also Exchange Compensation (SEC).

Why Is CLOV Stock Up Today?
Now, CLOV stock is up in response to Clinton’s purchase, which capitalists are deeming a favorable signal. Oftentimes, supervisor trading activity like this is important to track because experts frequently have a better sight of a company’s lasting growth possibility than retail financiers.

So, with that in mind, are various other experts of Clover favorable on the firm? In the past twelve month, insiders have bought 2.2 million shares and offered 22.9 million shares. That’s an internet of 20.6 million shares marketed. This mass insider selling appears to correlate with CLOV stock’s decline of more than 60% over the past one year.

Still, with Clinton’s recent acquisition, investors are questioning who else is betting huge on Clover Health and wellness. Let’s jump right in.

Who Else Is Betting Big on Clover Health And Wellness?
Since the 4th quarter, 160 institutional financiers own shares of CLOV stock. That marks a quarter-0ver-quarter (QOQ) boost of 8.8%. During the period, the total amount of shares held by institutional investors also raised from 105.7 million to 129.8 million, up nearly 23% QOQ. Allow’s take a look on top five institutional shareholders.

Vanguard has 25.9 million shares or 7.65% ownership. The company purchased 8.8 million shares during Q4.
Greenoaks Resources Allies owns 24.8 million shares or 7.34% ownership. The firm marketed 24.8 million shares throughout Q4.
Baillie Gifford has 7.8 million shares or 2.3% ownership. The company purchased 2.6 million shares during Q4.
Two Sigma Investments has 6.6 million shares or 1.95% possession. The firm bought all 6.6 million shares throughout Q4.
PNC Financial Provider (NYSE: PNC) has 6.4 million shares or 1.88% possession. The firm sold 249,850 shares during Q4.
Out of the leading five shareholders, 3 funds reduced their settings as well as 2 funds increased their placements. Greenoaks Capital Partners had one of the most noteworthy transaction, as the fund sold concerning 50% of its existing placement during Q4. Two Sigma’s 6.6 million share purchase was likewise noteworthy, as the acquisition placed it among the top five shareholders.